<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30575284</PMID><DateCompleted><Year>2020</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1467-7652</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Plant biotechnology journal</Title><ISOAbbreviation>Plant Biotechnol J</ISOAbbreviation></Journal><ArticleTitle>Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes.</ArticleTitle><Pagination><StartPage>1357</StartPage><EndPage>1368</EndPage><MedlinePgn>1357-1368</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/pbi.13060</ELocationID><Abstract><AbstractText>To prevent vaccine-associated paralytic poliomyelitis, WHO recommended withdrawal of Oral Polio Vaccine (Serotype-2) and a single dose of Inactivated Poliovirus Vaccine (IPV). IPV however is expensive, requires cold chain, injections and offers limited intestinal mucosal immunity, essential to prevent polio reinfection in countries with open sewer system. To date, there is no virus-free and cold chain-free polio vaccine capable of inducing robust mucosal immunity. We report here a novel low-cost, cold chain/poliovirus-free, booster vaccine using poliovirus capsid protein (VP1, conserved in all serotypes) fused with cholera non-toxic B subunit (CTB) expressed in lettuce chloroplasts. PCR using unique primer sets confirmed site-specific integration of CTB-VP1 transgene cassettes. Absence of the native chloroplast genome in Southern blots confirmed homoplasmy. Codon optimization of the VP1 coding sequence enhanced its expression 9-15-fold in chloroplasts. GM1-ganglioside receptor-binding ELISA confirmed pentamer assembly of CTB-VP1 fusion protein, fulfilling a key requirement for oral antigen delivery through gut epithelium. Transmission Electron Microscope images and hydrodynamic radius analysis confirmed VP1-VLPs of 22.3&#xa0;nm size. Mice primed with IPV and boosted three times with lyophilized plant cells expressing CTB-VP1co, formulated with plant-derived oral adjuvants, enhanced VP1-specific IgG1, VP1-IgA titres and neutralization (80%-100% seropositivity of Sabin-1, 2, 3). In contrast, IPV single dose resulted in &lt;50% VP1-IgG1 and negligible VP1-IgA titres, poor neutralization and seropositivity (&lt;20%, &lt;40% Sabin 1,2). Mice orally boosted with CTB-VP1co, without IPV priming, failed to produce any protective neutralizing antibody. Because global population is receiving IPV single dose, booster vaccine free of poliovirus or cold chain offers a timely low-cost solution to eradicate polio.</AbstractText><CopyrightInformation>&#xa9; 2018 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daniell</LastName><ForeName>Henry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4485-1176</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Vineeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EY024564</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL109442</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OPP1031406</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY 024564</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL107904</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL107904</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL109442</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Plant Biotechnol J</MedlineTA><NlmUniqueID>101201889</NlmUniqueID><ISSNLinking>1467-7644</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002736" MajorTopicYN="N">Chloroplasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007117" MajorTopicYN="N">Immunization, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018545" MajorTopicYN="N">Lactuca</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030821" MajorTopicYN="N">Plants, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012034" MajorTopicYN="Y">Refrigeration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Polio viral protein 1</Keyword><Keyword MajorTopicYN="N">bioencapsulation</Keyword><Keyword MajorTopicYN="N">human infectious diseases</Keyword><Keyword MajorTopicYN="N">lettuce chloroplast transformation</Keyword><Keyword MajorTopicYN="N">mucosal immunity</Keyword><Keyword MajorTopicYN="N">oral delivery</Keyword></KeywordList><CoiStatement>Henry Daniell, has several patents in the field of chloroplast genetic engineering and production of biopharmaceuticals in chloroplasts. Google Scholar link is provided http://scholar.google.com/citations?user=7sow4jwAAAAJ&amp;hl=en for full disclosure of these patents. However, he has no specific financial conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30575284</ArticleId><ArticleId IdType="mid">NIHMS1003598</ArticleId><ArticleId IdType="pmc">PMC6576100</ArticleId><ArticleId IdType="doi">10.1111/pbi.13060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allen, G.C. , Flores&#x2010;Vergara, M.A. , Krasynanski, S. , Kumar, S. and Thompson, W.F. (2006) A modified protocol for rapid DNA isolation from plant tissues using cetyltrimethylammonium bromide. Nat. Protoc. 1, 2320&#x2013;2325.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406474</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlen, P.A. , Falconer, R. , Cherukumilli, S. , Cole, A. , Cole, A.M. , Oishi, K.K. and Daniell, H. (2007) Field production and functional evaluation of chloroplast&#x2010;derived interferon&#x2010;alpha2b. Plant Biotechnol. J. 5, 511&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596645</ArticleId><ArticleId IdType="pubmed">17490449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachmann, M.F. and Jennings, G.T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat. Rev. Immunol. 10, 787&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">20948547</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldauf, K.J. , Royal, J.M. , Hamorsky, K.T. and Matoba, N. (2015) Cholera toxin B: one subunit with many pharmaceutical applications. Toxins, 7, 974&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4379537</ArticleId><ArticleId IdType="pubmed">25802972</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyhan, D. and Daniell, H. (2011) Low&#x2010;cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C&#x2010;peptide. Plant Biotechnol. J. 9, 585&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3480330</ArticleId><ArticleId IdType="pubmed">21143365</ArticleId></ArticleIdList></Reference><Reference><Citation>Byberg, S. and Fisker, A.B. (2016) Is introduction of IPV &#x201c;Good news for billions of children?&#x201d; Lancet Infect. Dis. 16, 409.</Citation><ArticleIdList><ArticleId IdType="pubmed">27036344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, H.T. , Xiao, Y. , Weldon, W.C. , Oberste, S.M. , Chumakov, K. and Daniell, H. (2016) Cold chain and virus&#x2010;free chloroplast&#x2010;made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnol. J. 14, 2190&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5056803</ArticleId><ArticleId IdType="pubmed">27155248</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Q. and Lai, H. (2013) Plant&#x2010;derived virus&#x2010;like particles as vaccines. Hum. Vaccin. Immunother. 9, 26&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3667944</ArticleId><ArticleId IdType="pubmed">22995837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. , Zhang, J. and Sun, H. (2015) Immunological adjuvant effect of the peptide fraction from the larvae of Musca domestica . BMC Complement Altern. Med. 15, 427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4668601</ArticleId><ArticleId IdType="pubmed">26630909</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniell, H. , Chan, H.T. and Pasoreck, E.K. (2016) Vaccination via chloroplast genetics: affordable protein drugs for the prevention and treatment of inherited or infectious human diseases. Annu. Rev. Genet. 50, 595&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496655</ArticleId><ArticleId IdType="pubmed">27893966</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoodi&#x2010;Semiromi, A. , Schreiber, M. , Nalapalli, S. , Verma, D. , Singh, N.D. , Banks, R.K. , Chakrabarti, D. et&#xa0;al (2010) Chloroplast&#x2010;derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J. 8, 223&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2807910</ArticleId><ArticleId IdType="pubmed">20051036</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop, O.M. , Burns, C.C. , Sutter, R.W. , Wassilak, S.G. , Kew, O.M. and Centers for Disease C Prevention (2015) Update on vaccine&#x2010;derived polioviruses &#x2013; Worldwide, January 2014&#x2010;March 2015. MMWR Morb. Mortal. Wkly Rep. 64, 640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584736</ArticleId><ArticleId IdType="pubmed">26086635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez&#x2010;San Millan, A. , Mingo&#x2010;Castel, A. , Miller, M. and Daniell, H. (2003) A chloroplast transgenic approach to hyper&#x2010;express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradation. Plant Biotechnol. J. 1, 71&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3481847</ArticleId><ArticleId IdType="pubmed">17147744</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey, A. , Di Canzio, J. and Zurakowski, D. (1998) A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods, 221, 35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9894896</ArticleId></ArticleIdList></Reference><Reference><Citation>Grgacic, E.V. and Anderson, D.A. (2006) Virus&#x2010;like particles: passport to immune recognition. Methods, 40, 60&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128828</ArticleId><ArticleId IdType="pubmed">16997714</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, K. , Kotian, A. , Subramanian, H. , Daniell, H. and Ali, H. (2015) Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties. Oncotarget, 6, 28573&#x2013;28587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4745678</ArticleId><ArticleId IdType="pubmed">26378047</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog, R.W. , Nichols, T.C. , Su, J. , Zhang, B. , Sherman, A. , Merricks, E.P. , Raymer, R. et&#xa0;al (2017) Oral tolerance induction in hemophilia b dogs fed with transplastomic lettuce. Mol. Ther. 25, 512&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5368425</ArticleId><ArticleId IdType="pubmed">28153098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hird, T.R. and Grassly, N.C. (2012) Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. PLoS Pathog. 8, 19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3330118</ArticleId><ArticleId IdType="pubmed">22532797</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes, M. , Abimbola, T. , Lusiana, M. , Pallas, S. , Hampton, L.M. , Widyastuti, R. , Muas, I. et&#xa0;al (2017) Resource needs for the trivalent oral polio to bivalent oral polio vaccine switch in Indonesia. J. Infect. Dis. 216, S209&#x2013;S216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853418</ArticleId><ArticleId IdType="pubmed">28838204</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba, J. , Diop, O.M. , Iber, J. , Henderson, E. , Sutter, R.W. , Wassilak, S.G.F. and Burns, C.C. (2017) Update on vaccine&#x2010;derived polioviruses &#x2013; Worldwide, January 2016&#x2010;June 2017. MMWR Morb. Mortal. Wkly Rep. 66, 1185&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689216</ArticleId><ArticleId IdType="pubmed">29095803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanagaraj, A.P. , Verma, D. and Daniell, H. (2011) Expression of dengue&#x2010;3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol. Biol. 76, 323&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3468899</ArticleId><ArticleId IdType="pubmed">21431782</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani, N. , Perehinets, I. , Nitzan, D. , Popovic, D. , Moran, T. , Allahverdiyeva, V. , Huseynov, S. et&#xa0;al (2017) Responding to a cVDPV1 outbreak in Ukraine: implications, challenges and opportunities. Vaccine, 35, 4769&#x2013;4776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10465089</ArticleId><ArticleId IdType="pubmed">28528761</ArticleId></ArticleIdList></Reference><Reference><Citation>Koya, V. , Moayeri, M. , Leppla, M.S.H. and Daniell, H. (2005) Plant&#x2010;based vaccine: mice immunized with chloroplast&#x2010;derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect. Immun. 73, 8266&#x2013;8274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1307059</ArticleId><ArticleId IdType="pubmed">16299323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, S. and Daniell, H. (2004) Engineering the chloroplast genome for hyperexpression of human therapeutic proteins and vaccine antigens. Methods Mol. Biol. 267, 365&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">15269437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushnir, N. , Streatfield, S.J. and Yusibov, V. (2012) Virus&#x2010;like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine, 31, 58&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7115575</ArticleId><ArticleId IdType="pubmed">23142589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, K.C. and Daniell, H. (2015) Low&#x2010;cost oral delivery of protein drugs bioencapsulated in plant cells. Plant Biotechnol. J. 13, 1017&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769795</ArticleId><ArticleId IdType="pubmed">26333301</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, K.C. and Daniell, H. (2016) Oral delivery of protein drugs bioencapsulated in plant cells. Mol. Ther. 24, 1342&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023392</ArticleId><ArticleId IdType="pubmed">27378236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, K.C. , Chan, H.T. , Leon, I.R. , Williams&#x2010;Carrier, R. , Barkan, A. and Daniell, H. (2016) Codon&#x2010;optimization to enhance expression yields insights into chloroplast translation. Plant Physiol. 172, 62&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5074611</ArticleId><ArticleId IdType="pubmed">27465114</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, K.C. , Sherman, A. , Chang, W.J. , Kamesh, A. , Biswas, M. , Herzog, R.W. and Daniell, H. (2018) Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice. Plant Biotechnol. J. 16, 1148&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5936678</ArticleId><ArticleId IdType="pubmed">29106782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakshmi, P.S. , Verma, D. , Yang, X. , Lloyd, B. and Daniell, H. (2013) Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio&#x2010;encapsulation, stability and functional evaluation in&#xa0;vitro . PLoS One, 8, 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552857</ArticleId><ArticleId IdType="pubmed">23355891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi, P. , Scotti, N. , Alagna, F. , Tornesello, M.L. , Pompa, A. , Vitale, A. , De Stradis, A. et&#xa0;al (2008) Translational fusion of chloroplast&#x2010;expressed human papillomavirus type 16&#xa0;L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Res. 17, 1091&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">18491213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund, N. , Andersen, A. , Hansen, A.S.K. , Jepsen, F.S. , Barbosa, A. , Biering&#x2010;S&#xf8;rensen, S. , Rodrigues, A. et&#xa0;al (2015) The effect of oral polio vaccine at birth on infant mortality: a randomized trial. Clin. Infect. Dis. 61, 1504&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4614411</ArticleId><ArticleId IdType="pubmed">26219694</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsian, J. and Lomonossoff, G.P. (2016) Molecular pharming &#x2013; VLPs made in plants. Curr. Opin. Biotechnol. 37, 201&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">26773389</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsian, J. , Fox, H. , Bahar, M.W. , Kotecha, A. , Fry, E.E. , Stuart, D.I. , Macadam, A.J. et&#xa0;al (2017) Plant&#x2010;made polio type 3 stabilized VLPs&#x2010;a candidate synthetic polio vaccine. Nat. Commun. 8, 245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557999</ArticleId><ArticleId IdType="pubmed">28811473</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy, K.A. , Chabot&#x2010;Couture, G. , Famulare, M. , Lyons, H.M. and Mercer, L.D. (2017) The risk of type 2 oral polio vaccine use in post&#x2010;cessation outbreak response. BMC Med. 15, 175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5627419</ArticleId><ArticleId IdType="pubmed">28974220</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor, P. (2009) Vaccine&#x2010;derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine, 27, 2649&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pubmed">19428874</ArticleId></ArticleIdList></Reference><Reference><Citation>Previsani, N. , Singh, H. , St Pierre, J. , Boualam, L. , Fournier&#x2010;Caruana, J. , Sutter, R.W. , Zaffran, M. et&#xa0;al (2017) Progress toward containment of poliovirus type 2 &#x2013; Worldwide, 2017. MMWR Morb. Mortal. Wkly Rep. 66, 649&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657795</ArticleId><ArticleId IdType="pubmed">28640795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez Gonzalez, A. , Farrell, M. , Menning, L. , Garon, J. , Everts, H. , Hampton, L.M. , Dolan, S.B. et&#xa0;al (2017) Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines&#x2010;lessons learned from the global perspective. J. Infect. Dis. 216, S183&#x2013;S192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854099</ArticleId><ArticleId IdType="pubmed">28838179</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennels, M.B. (2009) Need for polio boosters after age two years. Vaccine, 27, 179&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">19007837</ArticleId></ArticleIdList></Reference><Reference><Citation>Roldao, A. , Mellado, M.C. , Castilho, L.R. , Carrondo, M.J. and Alves, P.M. (2010) Virus&#x2010;like particles in vaccine development. Expert Rev. Vaccines, 9, 1149&#x2013;1176.</Citation><ArticleIdList><ArticleId IdType="pubmed">20923267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhlman, T. , Ahangari, R. , Devine, A. , Samsam, M. and Daniell, H. (2007) Expression of cholera toxin B&#x2010;proinsulin fusion protein in lettuce and tobacco chloroplasts&#x2010;oral administration protects against development of insulitis in non&#x2010;obese diabetic mice. Plant Biotechnol. J. 5, 495&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2590789</ArticleId><ArticleId IdType="pubmed">17490448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruhlman, T. , Verma, D. , Samson, N. and Daniell, H. (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol. 152, 2088&#x2013;2104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850035</ArticleId><ArticleId IdType="pubmed">20130101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman, A. , Su, J. , Lin, S. , Wang, X. , Herzog, R.W. and Daniell, H. (2014) Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood, 124, 1659&#x2013;1668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4155273</ArticleId><ArticleId IdType="pubmed">24825864</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratmann, T. (2015) Cholera toxin subunit B as adjuvant&#x2010;an accelerator in protective immunity and a break in autoimmunity. Vaccines, 3, 579&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4586468</ArticleId><ArticleId IdType="pubmed">26350596</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, J. , Zhu, L. , Sherman, A. , Wang, X. , Lin, S. , Kamesh, A. , Norikane, J.H. et&#xa0;al (2015) Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. Biomaterials, 70, 84&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562874</ArticleId><ArticleId IdType="pubmed">26302233</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma, D. , Moghimi, B. , LoDuca, P.A. , Singh, H.D. , Hoffman, B.E. , Herzog, R.W. and Daniell, H. (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc. Natl. Acad. Sci. USA, 107, 7101&#x2013;7106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2872434</ArticleId><ArticleId IdType="pubmed">20351275</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed, M.T. , Thones, N. , Muller, M. , Hassan, S.W. , Razavi, N.M. , Lossl, E. , Kaul, H.P. et&#xa0;al (2011) Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost&#x2010;effective second&#x2010;generation vaccines. Transgenic Res. 20, 271&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">20563641</ArticleId></ArticleIdList></Reference><Reference><Citation>Worstell, N.C. , Krishnan, P. , Weatherston, J.D. and Wu, H.J. (2016) Binding cooperativity matters: a GM1&#x2010;like ganglioside&#x2010;cholera toxin B subunit binding study using a nanocube&#x2010;based lipid bilayer array. PLoS One, 11, e0153265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829222</ArticleId><ArticleId IdType="pubmed">27070150</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, Y. and Daniell, H. (2017) Long&#x2010;term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines. Vaccine, 35, 5418&#x2013;5425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5517362</ArticleId><ArticleId IdType="pubmed">28111147</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, Y. , Kwon, K.C. , Hoffman, B.E. , Kamesh, A. , Jones, N.T. , Herzog, R.W. and Daniell, H. (2016) Low cost delivery of proteins bioencapsulated in plant cells to human non&#x2010;immune or immune modulatory cells. Biomaterials, 80, 68&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706487</ArticleId><ArticleId IdType="pubmed">26706477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaari, R. , Kaliner, E. , Grotto, I. , Katriel, G. , Moran&#x2010;Gilad, J. , Sofer, D. , Mendelson, E. et&#xa0;al (2016) Modeling the spread of polio in an IPV&#x2010;vaccinated population: lessons learnedfrom the 2013 silent outbreak in southern Israel. BMC Med. 14, 95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918056</ArticleId><ArticleId IdType="pubmed">27334457</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>